Announced Mon, 29 Jun · 12:34 IST
Dr. Lal PathLabs board meeting on July 24 for Q1 FY27 results; trading window closed July 1-26
Results View source PDF
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹1691.00
prior close
₹1623.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.2-0.4-0.2-2.6-3.9-2.4-2.4+0.0-2.0+0.4———
Up moveDown movePending
AI summary
Dr. Lal PathLabs has informed exchanges that its Board of Directors will meet on Friday, July 24, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter ending June 30, 2026 (Q1 FY27). The trading window for dealing in company securities will remain closed from July 1 to July 26, 2026, both days inclusive, in line with SEBI insider trading regulations. Insiders and designated persons cannot trade in the stock during this window.
Likely market impact
Routine compliance filing. No material business impact. Q1 FY27 results due around July 24 may move the stock based on performance.